Disclosures
Marinos C. Dalakas, MD, FAAN
| Scientific Advisory Boards | |
| Serves on the CIDP DSMB for Baxalta and Octapharma | |
| Funding for travel or speaker honoraria | |
| Merck/Serono, OCTAPHARMA, PFIZER AG, | |
| Editorial Boards | |
| 1. Neurology, editorial board (5 years, not compensated); 2)BMC Neurology (Section Editor, 5 years not compensated); 3) Acta Myologica, editorial board (5 years, not compensated); 5)Acta Neurologica Scandinavica editorial board ( 5 years, not compensated); 6)Therapeutic Advances in Neurology (Associate Editor; 4 years, compensated); 7) Annals of Neurology (3 years not compensated); 8) Neurology, Neuroimmunology Neuroinflammation (Associate Editor, compensated); 9)Neurodiem (Associate editor, compensated) | |
| Consultancies | |
| Therapath, Baxter, Octapharma, Dysimmune Diseases Foundation | |
| Research Support, Commercial Entities | |
| Received Institutional support to Thomas Jefferson University Neurology department or to Neuroimmunology Unit, University of Athens Medical School for research and education from: Merck-Serono, Genzyme, Novartis, Guillain-Barre/CIDP Foundation, Dysimmune diseases Foundation, InfuCare, and Newfactor | |